Stock was at $65 after the news and today they had it down to $51. Seems like retail is throwing in shares trying to protect some of the gain from the deal.
Hope the CNBC doc knows his stuff.
Weak institutional ownership at about 24%. This might explain some of this, imo.
That news yesterday should be attention getting for the tutes who usually think about things for a day or two before buying stock.
No clue so far.
The pattern is even noticeable today as there is size involved on the buy side and when there is an offer it gets taken out.
If your going to scream at anyone in this company go straight to the top and do it in the board room where our watchdogs are supposed to be...
Those are the people that need to hear an ear full. Don't vote for any of them in the upcoming election.
I would agree with the nanosecond comment.
Looks like it will be closer to $70 billion...
The problem with this is that Arena only gets royalties off Belviq sales and that Eisai would still have control of this drug therefore it takes a lot of trust to want to go this far for such a small percentage of the pot. I suppose that this drug for this usage would be easier for them to sell...